Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study

Scandinavian Journal of Infectious Diseases
I KuzmanJ Culig

Abstract

A clinical, retrospective and non-comparative study was undertaken to assess the clinical efficacy and tolerability of azithromycin in the treatment of community-acquired pneumonia caused by Legionella pneumophila. A total of 16 patients with a serologically confirmed diagnosis of Legionnaires' diseases were included. Azithromycin was administered orally at a total dose of 1.5 g for either 3 or 5 days. All patients were no side-effects requiring discontinuation of the treatment. Further increase of abnormal baseline liver function was recorded in 2 patients and in 1 patient mild, transient eosinophilia. Equal clinical efficacy and tolerability were observed with the 3- and 5-day dosage regimen. These results indicate that azithromycin given at a standard dose of 1.5 g is effective and well tolerated in the treatment of Legionnaires' disease.

References

Oct 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D L MorrisW E Morgan
Oct 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S SchönwaldM Gunjaca
Sep 1, 1991·The Journal of Hospital Infection·P Ball
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·P H Edelstein, M A Edelstein
Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·R B FitzgeorgeA Baskerville
Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·S SchönwaldM Gosev
Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·G FouldsR B Johnson
Jul 1, 1989·Reviews of Infectious Diseases·T J MarrieL Yates
Oct 1, 1988·The Journal of Antimicrobial Chemotherapy·B G Moffie, R P Mouton
Jan 1, 1986·Scandinavian Journal of Infectious Diseases·A Friis-MøllerO Aalund
May 1, 1985·The Journal of Infection·A MercatelloF Fleurette
Jul 31, 1982·Lancet·J T MacfarlaneA D Macrae
Mar 1, 1981·The Journal of Antimicrobial Chemotherapy·A C Miller
Jan 1, 1981·Scandinavian Journal of Infectious Diseases·M WalderA Forsgren
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·S SchönwaldM Gunjaca
Apr 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J Marrie

❮ Previous
Next ❯

Citations

Aug 1, 1997·Diagnostic Microbiology and Infectious Disease·J SchrockJ F Plouffe
Sep 4, 1997·The New England Journal of Medicine·J E Stout, V L Yu
Jan 24, 1998·The New England Journal of Medicine·P H Edelstein
Sep 30, 2005·Acta Dermato-venereologica·Leonardo CalzaTiziano Zauli
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S TanJ E Stout
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F SánchezA Torres
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph F PlouffeDouglas B Schwartz
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Victor L YuMiguel Sabria
Dec 31, 1997·The Pediatric Infectious Disease Journal·M D Reed, J L Blumer
Mar 8, 2005·Drugs·Guy W Amsden
Aug 2, 2015·Lancet·Burke A CunhaEmilio Bouza
Oct 12, 1999·Clinics in Chest Medicine·D Lieberman
Dec 3, 2016·Journal of Medical Case Reports·Stephanie CargnelliJennifer L Y Tsang
Jul 15, 1999·The Journal of Antimicrobial Chemotherapy·M Dedicoat, P Venkatesan
May 2, 2009·Expert Opinion on Pharmacotherapy·M Luisa Pedro-Botet, Victor L Yu
Sep 13, 2000·Drugs & Aging·D Lieberman, D Lieberman
Aug 15, 2020·Respiratory Medicine Case Reports·Chee H Loh, Rajeev Soni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.